P. Tamma

发表

Outcomes of Children With Enterobacteriaceae Bacteremia With Reduced Susceptibility to Ceftriaxone: Do the Revised Breakpoints Translate to Improved Patient Outcomes?

S. Cosgrove, K. Carroll, P. Tamma, 2013, The Pediatric infectious disease journal.

A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia

J. Lessler, P. Tamma, A. Harris, 2019, Infection Control & Hospital Epidemiology.

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

Pranita D. Tamma, Lisa L. Maragakis, Sara E. Cosgrove, 2012, Clinical Microbiology Reviews.

Association of Adverse Events With Antibiotic Use in Hospitalized Patients

S. Cosgrove, P. Tamma, E. Avdic, 2017, JAMA internal medicine.

Research needs in antibiotic stewardship

Jessina C. McGregor, P. Tamma, S. Fridkin, 2019, Infection Control & Hospital Epidemiology.

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review

A. Gurses, S. Cosgrove, Melissa A. Miller, 2018, The Journal of the American Board of Family Medicine.

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children

W. Bilker, P. Tamma, T. Zaoutis, 2018, Open forum infectious diseases.

Safety of influenza vaccination during pregnancy.

C. del Rio, P. Tamma, K. Ault, 2009, American journal of obstetrics and gynecology.

Safety of Influenza Vaccination During Pregnancy

P. Tamma, K. Ault, S. Omer, 2011 .

Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting

P. Tamma, N. Fishman, L. Abbo, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens

K. Carroll, P. Tamma, Y. Bergman, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs

K. Carroll, P. Tamma, K. Goodman, 2019, Journal of Clinical Microbiology.

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates

P. Tamma, P. Simner, 2018, Journal of Clinical Microbiology.

Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae

K. Carroll, P. Tamma, P. Simner, 2017, Journal of Clinical Microbiology.

Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs

K. Carroll, P. Tamma, A. Milstone, 2016, Journal of Clinical Microbiology.

Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort

S. Cosgrove, P. Tamma, A. Harris, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.

S. Cosgrove, P. Tamma, A. J. Hsu, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Empiric Combination Therapy for Gram-Negative Bacteremia

P. Tamma, S. Tschudin-Sutter, S. Weissman, 2014, Pediatrics.

Use of PNA FISH for blood cultures growing Gram-positive cocci in chains without a concomitant antibiotic stewardship intervention does not improve time to appropriate antibiotic therapy.

S. Cosgrove, K. Carroll, P. Tamma, 2016, Diagnostic microbiology and infectious disease.

Addressing the Appropriateness of Outpatient Antibiotic Prescribing in the United States: An Important First Step.

S. Cosgrove, P. Tamma, 2016, JAMA.

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?

S. Cosgrove, P. Tamma, Valeria Fabre, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Al-Hasan et al.

S. Cosgrove, P. Tamma, A. Harris, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Peripherally Inserted Central Venous Catheter Complications in Children Receiving Outpatient Parenteral Antibiotic Therapy (OPAT)

P. Tamma, A. Milstone, Sonali D. Advani, 2016, Infection Control & Hospital Epidemiology.

Antimicrobial stewardship: another focus for patient safety?

P. Tamma, A. Holmes, E. Ashley, 2014, Current opinion in infectious diseases.

Ventilator-associated tracheitis in children: does antibiotic duration matter?

Christoph U. Lehmann, S. Cosgrove, P. Tamma, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy

A. Gurses, S. Cosgrove, P. Tamma, 2020, Open forum infectious diseases.

Sustained Savings from a Longitudinal Cost Analysis of an Internet-Based Preapproval Antimicrobial Stewardship Program

Christoph U. Lehmann, P. Tamma, Carlton K. K. Lee, 2013, Infection Control & Hospital Epidemiology.

Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis

P. Tamma, Y. Bergman, Stephan Beisken, 2022, JAC-antimicrobial resistance.

Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance

Andreas E. Posch, S. Cosgrove, P. Tamma, 2021, Open forum infectious diseases.

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress

R. Humphries, P. Tamma, 2021, JAC-antimicrobial resistance.

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States

P. Tamma, Tsigereda Tekle, S. Sharara, 2019, Open forum infectious diseases.

How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?

S. Cosgrove, E. Klein, P. Tamma, 2018, Infection Control & Hospital Epidemiology.

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms

K. Carroll, P. Tamma, A. Harris, 2018, Open forum infectious diseases.

Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam

W. Timp, P. Tamma, A. J. Hsu, 2018, Antimicrobial Agents and Chemotherapy.

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms

P. Tamma, A. Schuetz, Sergio Reyes, 2017, Journal of Clinical Microbiology.

Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals

S. Cosgrove, Melissa A. Miller, P. Tamma, 2021, JAMA network open.

Does prolonged b-lactam infusions improve clinical outcomes compared to intermittent infusions ? A meta-analysis and systematic review of randomized , controlled trials

P. Tamma, N. Putcha, M. L. Rinke, 2016 .

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials

P. Tamma, N. Putcha, M. L. Rinke, 2011, BMC infectious diseases.

Extended-interval Aminoglycoside Dosing in Pediatrics

P. Tamma, A. Milstone, Alice M Jenh, 2011, The Pediatric infectious disease journal.

Comparing Propensity Score Methods versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections.

E. Stuart, S. Cosgrove, P. Tamma, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.

P. Tamma, M. Melia, Anna T Conley, 2017, The American journal of medicine.

Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children

P. Tamma, Sean X. Zhang, Alice J. Hsu, 2021, Journal of clinical microbiology.

Chlorhexidine Use in the Neonatal Intensive Care Unit: Results from a National Survey

P. Tamma, S. Aucott, A. Milstone, 2010, Infection Control & Hospital Epidemiology.

Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection

Ryan D. Crawford, E. Snitkin, P. Tamma, 2022, Nature Communications.

Antibiotics: how can we make it as Easy to Stop as it is to Start? Editorial commentary on: Antibiotics: Easier to Start than to Stop? Predictors of Antimicrobial Stewardship Recommendation Acceptance.

P. Tamma, K. Chiotos, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Policy Statement: Antibiotic Stewardship in Pediatrics.

Prachi Singh, R. Lynfield, P. Tamma, 2021, Journal of the Pediatric Infectious Diseases Society.

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients.

S. Cosgrove, P. Tamma, D. Morgan, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sustained Impact of an Antibiotic Stewardship Intervention for Community-Acquired Pneumonia

S. Cosgrove, P. Tamma, E. Avdic, 2016, Infection Control & Hospital Epidemiology.

The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.

R. Weinstein, Robin Patel, P. Tamma, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

What Is the More Effective Antibiotic Stewardship Intervention: Preprescription Authorization or Postprescription Review With Feedback?

S. Cosgrove, P. Tamma, R. Dezube, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next

L. Saiman, P. Tamma, J. Gerber, 2017, Journal of the Pediatric Infectious Diseases Society.

Multidrug-resistant gram-negative infections in transplant and oncology patients

P. Tamma, A. Nowalk, M. Arshad, 2021 .

Antibiotic-Associated Adverse Events in Hospitalized Children.

S. Cosgrove, E. Klein, P. Tamma, 2021, Journal of the Pediatric Infectious Diseases Society.

Comparative Effectiveness of Antibiotic Treatment Duration in Children With Pyelonephritis

P. Tamma, J. Gerber, C. Herzke, 2020, JAMA network open.

The Impact of Mental Health on Antibiotic Prescribing

P. Tamma, S. Keller, 2022, The Joint Commission Journal on Quality and Patient Safety.

Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.

P. Tamma, T. Perl, S. Tschudin-Sutter, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients

S. Cosgrove, P. Tamma, Darunee Chotiprasitsakul, 2018, Infection Control & Hospital Epidemiology.

Risk Factors for Persistent Methicillin-Resistant Staphylococcus aureus Colonization in Children with Multiple Intensive Care Unit Admissions

N. Reich, P. Tamma, T. Perl, 2013, Infection Control & Hospital Epidemiology.

The Prediction of Complicated Clostridium difficile Infections in Children

P. Tamma, T. Perl, S. Tschudin-Sutter, 2014, Infection Control & Hospital Epidemiology.

Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms?

S. Cosgrove, P. Tamma, S. Sharara, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among Enterobacteriaceae

P. Tamma, Y. Bergman, P. Májek, 2022, Frontiers in Microbiology.

An Outbreak of Extended-Spectrum β-Lactamase–Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit

P. Tamma, T. Perl, A. Milstone, 2012, Infection Control & Hospital Epidemiology.

The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit

K. Carroll, P. Tamma, Tsigereda Tekle, 2016, Infection Control & Hospital Epidemiology.

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

S. Cosgrove, P. Tamma, A. Harris, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New Perspectives on Antimicrobial Agents: Cefiderocol

P. Tamma, E. McCreary, E. Heil, 2021, Antimicrobial agents and chemotherapy.

Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance.

Andreas E. Posch, S. Cosgrove, P. Tamma, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children

P. Tamma, B. Fisher, Alice J. Hsu, 2022, Antimicrobial agents and chemotherapy.

The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children.

S. Cosgrove, P. Tamma, A. Hersh, 2020, Journal of the Pediatric Infectious Diseases Society.

Duration of antibiotic therapy for community-acquired pneumonia in children.

S. Cosgrove, P. Tamma, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children

P. Tamma, M. J. Wingler, 2022, Current opinion in infectious diseases.

Campylobacter Infections in Children

P. Tamma, Rebecca G Same, 2018, Pediatrics in Review.

D‐dimer for the diagnosis of venous thromboembolism in children

P. Tamma, J. Strouse, C. Takemoto, 2009, American journal of hematology.

Carbapenem-Resistant Enterobacteriaceae Infections in Children

P. Tamma, Jennifer H. Han, K. Chiotos, 2015, Current Infectious Disease Reports.

Infections in Patients Colonized with Extended-Spectrum Beta-Lactamase-Producing Enterobacterales - a Retrospective Cohort Study.

P. Tamma, S. Tschudin-Sutter, A. Egli, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosis and Management of Clostridium difficile Infection by Pediatric Infectious Diseases Physicians.

P. Polgreen, P. Tamma, J. Gerber, 2014, Journal of the Pediatric Infectious Diseases Society.

Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms

W. Timp, P. Tamma, S. Hao, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms

W. Timp, P. Tamma, S. Hao, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Infectious Disease Clinics of North America. Antimicrobial stewardship. Preface.

S. Cosgrove, P. Tamma, A. Srinivasan, 2014, Infectious disease clinics of North America.

Behavior Outbursts, Orofacial Dyskinesias, and CSF Pleocytosis in a Healthy Child

P. Tamma, A. Hartman, A. Agwu, 2011, Pediatrics.

Index of suspicion, case 1: hemoptysis, dyspnea, and hematuria, case 2: rash and headache in a wrestler, case 3: abdominal distention in a teenage girl.

Therese L. Canares, P. Tamma, Joanne M. Nazif, 2010, Pediatrics in review.

Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study

Suzannah M. Schmidt-Malan, P. Tamma, V. Fowler, 2022, Open forum infectious diseases.

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase-Producing Organism.

Pranita D. Tamma, Aaron M. Milstone, Anthony D. Harris, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World.

P. Tamma, R. Bonomo, Y. Doi, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients.

Kerri A. Thom, W. Bilker, P. Tamma, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population

P. Tamma, M. Villegas, 2017, Antimicrobial Agents and Chemotherapy.

The Use of Noncarbapenem &bgr;-Lactams for the Treatment of Extended-Spectrum &bgr;-Lactamase Infections

P. Tamma, J. Rodríguez-Baño, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China

Y. Liu, F. Chen, P. Tamma, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Prevalence of blaCTX-M Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States

P. Tamma, P. Simner, Natalie N. Whitfield, 2021, Journal of Clinical Microbiology.

The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.

S. Cosgrove, K. Carroll, P. Tamma, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)

P. Tamma, K. Goodman, A. Milstone, 2016, Expert review of anti-infective therapy.

The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria

P. Tamma, M. Plazak, E. Heil, 2018, Expert opinion on pharmacotherapy.

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

P. Tamma, R. Bonomo, D. van Duin, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single Academic Center Experience of Unrestricted β-d-Glucan Implementation

S. Cosgrove, P. Tamma, Sean X. Zhang, 2018, Open forum infectious diseases.

Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients

W. Bilker, P. Tamma, L. Pineles, 2022, Transplantation.

Risk factors for colonization with multiple species of extended-spectrum beta-lactamase producing Enterobacterales: a case-case–control study

P. Tamma, S. Tschudin-Sutter, A. Egli, 2021, Antimicrobial Resistance & Infection Control.

Clinical prediction tool for extended‐spectrum beta‐lactamase‐producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients

W. Bilker, P. Tamma, K. Thom, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Determining the Optimal Ceftriaxone MIC for Triggering Extended-Spectrum β-Lactamase Confirmatory Testing

S. Cosgrove, K. Carroll, P. Tamma, 2014, Journal of Clinical Microbiology.

Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections.

P. Tamma, R. Bonomo, D. van Duin, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.

P. Tamma, J. Gerber, M. Hayes, 2019, Journal of the Pediatric Infectious Diseases Society.

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

P. Tamma, Alice J. Hsu, 2019, Journal of the Pediatric Infectious Diseases Society.

Treatment of multidrug-resistant Gram-negative infections in children.

P. Tamma, Alice J. Hsu, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Considerations for the Use of Phage Therapy in Clinical Practice

Robin Patel, P. Tamma, A. Harris, 2022, Antimicrobial agents and chemotherapy.

The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies

P. Tamma, D. Amanatullah, E. Burgener, 2021, Viruses.

The Safety and Toxicity of Phage Therapy: A Review of Pre-Clinical and Clinical Studies

P. Tamma, D. Amanatullah, E. Burgener, 2021 .

Phage Are All the Rage: Bacteriophage in Clinical Practice.

P. Tamma, G. Suh, 2021, Journal of the Pediatric Infectious Diseases Society.

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Vaccines in immunocompromised patients.

P. Tamma, 2010, Pediatrics in review.

The Use of Intravenous Colistin Among Children in the United States: Results From a Multicenter, Case Series

Talene A. Metjian, P. Polgreen, P. Tamma, 2013, The Pediatric infectious disease journal.

Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children

P. Tamma, Alice J. Hsu, 2014, Current opinion in infectious diseases.

Analysis of the optimal cut-point for HIV-p24 antigen testing to diagnose HIV infection in HIV-exposed children from resource-constrained settings.

P. Tamma, C. Thompson, D. Persaud, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli

K. Carroll, P. Tamma, P. Simner, 2017, Journal of Clinical Microbiology.

Use of colistin in children.

P. Tamma, Carlton K. K. Lee, 2009, The Pediatric infectious disease journal.

The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections

Karen C Carroll, Sara E Cosgrove, S. Cosgrove, 2015, Infection Control & Hospital Epidemiology.

Viridans streptococcal meningitis following penetrating cervical injury.

P. Tamma, J. Cantey, 2011, Pediatric emergency care.

Trends in Chlorhexidine Use in US Neonatal Intensive Care Units: Results From a Follow-Up National Survey

P. Tamma, C. Bearer, S. Aucott, 2016, Infection Control & Hospital Epidemiology.

Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children

W. Bilker, P. Tamma, T. Zaoutis, 2017, Antimicrobial Agents and Chemotherapy.

Antimicrobial stewardship.

S. Cosgrove, P. Tamma, 2011, Infectious disease clinics of North America.

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy Is Associated with Increased blaNDM-5 Copy Number and Gene Expression.

P. Tamma, Tsigereda Tekle, M. Ante, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza infection and vaccination in pregnant women

P. Tamma, S. Omer, M. Steinhoff, 2010, Expert review of respiratory medicine.

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia

S. Cosgrove, P. Tamma, A. Harris, 2019, JAMA internal medicine.

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia

S. Cosgrove, K. Carroll, P. Tamma, 2016, Open forum infectious diseases.

Disk Correlates for Revised Clinical and Laboratory Standards Institute Enterobacterales Piperacillin-Tazobactam MIC Breakpoints

R. Humphries, P. Tamma, A. Mathers, 2022, Journal of clinical microbiology.

Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications

P. Tamma, S. Tamma, Alice J. Hsu, 2016, Pediatric Drugs.

Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

S. Cosgrove, P. Tamma, A. Harris, 2013, JAMA pediatrics.

Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.

K. Carroll, P. Tamma, A. Milstone, 2018, Journal of the Pediatric Infectious Diseases Society.

Trends in pediatric community-onset Staphylococcus aureus antibiotic susceptibilities over a five-year period in a multihospital health system

K. Carroll, P. Tamma, A. Milstone, 2023, Antimicrobial Stewardship & Healthcare Epidemiology.

Pediatric Antimicrobial Susceptibility Trends across the United States

P. Tamma, J. Gerber, T. Zaoutis, 2013, Infection Control & Hospital Epidemiology.

Cefiderocol: the Trojan horse has arrived but will Troy fall?

P. Tamma, E. Heil, 2020, The Lancet. Infectious diseases.

P. Tamma, R. Bonomo, D. van Duin, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridium difficile Infection in Children: Current State and Unanswered Questions.

P. Tamma, T. Sandora, Thomas J. Sandora, 2012, Journal of the Pediatric Infectious Diseases Society.

Impact of an Antibiotic Stewardship Program on the Incidence of Vancomycin-Associated Acute Kidney Injury in Hospitalized Children.

P. Tamma, Alice J. Hsu, 2019, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

P. Tamma, Tsigereda Tekle, A. Harris, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae

M. Schatz, K. Carroll, W. Timp, 2018, The Journal of antimicrobial chemotherapy.

647: CARBAPENEM-RESISTANT ENTEROBACTERIACEAE: AN EMERGING PEDIATRIC PATHOGEN

W. Bilker, P. Tamma, T. Zaoutis, 2016, Critical care medicine.

Integrating bedside nurses into antibiotic stewardship: A practical approach

S. Cosgrove, Melissa A. Miller, P. Tamma, 2019, Infection Control & Hospital Epidemiology.

Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

Pranita D. Tamma, Michael C. Schatz, Geo Pertea, 2018, Antimicrobial Agents and Chemotherapy.

The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting.

S. Cosgrove, Melissa A. Miller, P. Tamma, 2019, Family practice.

Association of a blood culture utilization intervention on antibiotic use in a pediatric intensive care unit

Sybil A. Klaus, P. Tamma, J. Fackler, 2019, Infection Control & Hospital Epidemiology.

Reply to Nguyen et al.

P. Tamma, A. Milstone, D. Sklansky, 2014, Clinical Infectious Diseases.

Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.

S. Cosgrove, P. Tamma, E. Avdic, 2018, Diagnostic microbiology and infectious disease.

Antibiotic susceptibility of common pediatric uropathogens in the United States.

P. Tamma, A. Milstone, D. Sklansky, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries across 825 United States Hospitals, 2019-2020.

S. Cosgrove, L. Magder, P. Tamma, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia

S. Cosgrove, K. Carroll, P. Tamma, 2017, The Journal of antimicrobial chemotherapy.

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process

S. Cosgrove, David R Ha, P. Tamma, 2021, Open forum infectious diseases.

Thinking Beyond the "Core" Antibiotic Stewardship Interventions: Shifting the Onus for Appropriate Antibiotic Use from Stewardship Teams to Prescribing Clinicians.

P. Tamma, T. Jenkins, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children

P. Tamma, J. Gerber, A. Hersh, 2017, Pediatrics.

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy

S. Cosgrove, P. Tamma, Darunee Chotiprasitsakul, 2017, Infection Control & Hospital Epidemiology.

Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice

S. Cosgrove, Melissa A. Miller, P. Tamma, 2019, JAMA.

Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach

Ayse P Gurses, Sara E Cosgrove, A. Gurses, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia?

S. Cosgrove, K. Carroll, P. Tamma, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Do patient data really support the clinical and laboratory standards institute recommendation for lowering third-generation cephalosporin interpretive breakpoints?

J. Powers, P. Tamma, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Do patient data really support the CLSI recommendation for lowering third-generation cephalosporin interpretive breakpoints?

J. Powers, P. Tamma, 2013 .

Legal implications of antibiotic stewardship programs

P. Tamma, J. Szymczak, E. D. Dodds Ashley, 2020, Infection Control & Hospital Epidemiology.

Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients

J. Bartlett, K. Carroll, P. Tamma, 2015, Infection Control & Hospital Epidemiology.

Predictors of First Recurrence of Clostridium difficile Infections in Children

P. Tamma, T. Perl, S. Tschudin-Sutter, 2014, The Pediatric infectious disease journal.

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

R. Schooley, P. Tamma, D. Conrad, 2022, Trials.

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections

P. Tamma, D. Paterson, R. Shields, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children

P. Tamma, J. Gerber, A. Hersh, 2017, Journal of the Pediatric Infectious Diseases Society.

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals

L. Magder, P. Tamma, A. Harris, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship

L. Saiman, P. Tamma, J. Gerber, 2020, Infection Control & Hospital Epidemiology.

Antibiotic Stewardship in Pediatrics

P. Tamma, J. Gerber, T. Zaoutis, 2020, Pediatrics.

Let the games begin: the race to optimise antibiotic use.

S. Cosgrove, P. Tamma, 2014, The Lancet. Infectious diseases.

The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay

P. Tamma, Y. Bergman, K. Goodman, 2019, Antimicrobial Agents and Chemotherapy.

Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli

R. Humphries, J. Hindler, P. Tamma, 2018, Journal of Clinical Microbiology.

Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution

P. Tamma, Y. Bergman, P. Simner, 2020, Journal of Clinical Microbiology.

A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among Enterobacteriales

P. Tamma, Y. Bergman, P. Simner, 2019, Journal of Clinical Microbiology.

Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales.

Andreas E. Posch, P. Tamma, M. Ante, 2021, Microbial drug resistance.

Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant

P. Tamma, Y. Bergman, A. Mathers, 2023, Open Forum Infectious Diseases.

Can Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF) Enhance Antimicrobial Stewardship Efforts in the Acute Care Setting?

S. Cosgrove, K. Carroll, P. Tamma, 2013, Infection Control & Hospital Epidemiology.

Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae

P. Tamma, P. Simner, Belita N. A. Opene, 2016, Antimicrobial Agents and Chemotherapy.

Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates

S. Cosgrove, P. Tamma, Y. Bergman, 2022, Infection Control & Hospital Epidemiology.

Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?

P. Tamma, P. Simner, Ruibin Wang, 2017, Infection Control & Hospital Epidemiology.

A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Katherine E Goodman, Andrew J Nowalk, P. Tamma, 2019, Journal of the Pediatric Infectious Diseases Society.

Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission

P. Tamma, Nuntra Suwantarat, David X. Li, 2017, Infection Control & Hospital Epidemiology.

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

P. Tamma, R. Bonomo, D. van Duin, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia.

S. Cosgrove, P. Tamma, M. Diener-West, 2014, The Journal of antimicrobial chemotherapy.

The Role of Healthcare Worker-Mediated Contact Networks in the Transmission of Vancomycin-Resistant Enterococci

Matthew F. Toerper, E. Klein, P. Tamma, 2019, Open forum infectious diseases.

The galactomannan antigen assay.

P. Tamma, 2007, The Pediatric infectious disease journal.

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections

J. Thaden, P. Tamma, N. Daneman, 2022, JAC-antimicrobial resistance.

Variability in Oral Antibiotic Step-Down Therapy in the Management of Gram-Negative Bloodstream Infections.

J. Thaden, P. Tamma, N. Daneman, 2021, International journal of antimicrobial agents.

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections in Children: Translating Evidence From Adults Into Pediatric Practice.

P. Tamma, Rebecca G Same, Alice J. Hsu, 2019, Journal of the Pediatric Infectious Diseases Society.

Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic

S. Cosgrove, Melissa A. Miller, P. Tamma, 2022, JAMA network open.

Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies

P. Tamma, C. Arias, R. Shields, 2023, Antimicrobial Agents and Chemotherapy.

A framework for implementing antibiotic stewardship in ambulatory care: Lessons learned from the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use

S. Cosgrove, Melissa A. Miller, P. Tamma, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Implementation of an Antibiotic Stewardship Program in Long-term Care Facilities Across the US

S. Cosgrove, Melissa A. Miller, P. Tamma, 2022, JAMA network open.

Use of leading practices in US hospital antimicrobial stewardship programs

P. Tamma, L. Davidson, B. Braun, 2022, Infection Control & Hospital Epidemiology.

First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States.

K. Carroll, P. Tamma, R. Bonomo, 2016, Journal of the Pediatric Infectious Diseases Society.

Navigating treatment approaches for presumed ESBL-producing infections

P. Tamma, A. Mathers, 2021, JAC-antimicrobial resistance.

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission

Matthew F. Toerper, S. Cosgrove, E. Klein, 2019, Infection Control & Hospital Epidemiology.

An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury

S. Cosgrove, E. Klein, P. Tamma, 2023, Open forum infectious diseases.

Antibiotic stewardship in the intensive care unit: Challenges and opportunities

P. Tamma, J. Gerber, K. Chiotos, 2019, Infection Control & Hospital Epidemiology.

StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population

S. Cosgrove, P. Tamma, K. Goodman, 2021, Antimicrobial agents and chemotherapy.

Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor

P. Tamma, Sean X. Zhang, Carlton K. K. Lee, 2023, The Pediatric infectious disease journal.

Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin

P. Tamma, A. Milstone, W. Buckel, 2017, Pediatric Drugs.

Index of suspicion.

T. Loddenkemper, P. Tamma, R. Prayson, 2006, Pediatrics in review.

Outpatient antibiotic therapy for acute osteomyelitis in children: balancing safety and efficacy.

P. Tamma, A. Milstone, 2015, JAMA pediatrics.

Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing

P. Tamma, Y. Bergman, Thomas Weinmaier, 2022, Antimicrobial agents and chemotherapy.

Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections

P. Tamma, Jianyi Yin, L. Kociolek, 2019, Open forum infectious diseases.

Things We Do for No Reason™: Lumbar Punctures in Low-Risk Febrile Infants with Bronchiolitis.

P. Tamma, C. Herzke, J. Berk, 2019, Journal of hospital medicine.

Multicentre genetic diversity study of carbapenem-resistant Enterobacterales: predominance of untypeable pUVA-like blaKPC bearing plasmids

M. Schatz, K. Carroll, W. Timp, 2023, JAC-antimicrobial resistance.

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.

R. Humphries, P. Tamma, A. Mathers, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibacterial Resistance Leadership Group 2.0 - Back to Business.

Robin Patel, E. Tsalik, P. Tamma, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016

P. Tamma, S. Tschudin-Sutter, A. Egli, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.

P. Tamma, R. Bonomo, D. van Duin, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic indications and appropriateness in the pediatric intensive care unit: a ten-center point prevalence study.

P. Tamma, J. Gerber, J. Newland, 2022, Clinical Infectious Diseases.

Admission Laboratory Values Accurately Predict In-hospital Mortality: a Retrospective Cohort Study

L. Magder, P. Tamma, A. Harris, 2019, Journal of General Internal Medicine.

Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients

S. Cosgrove, P. Tamma, T. Perl, 2010, BMC pediatrics.

An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance

P. Tamma, Tsigereda Tekle, Y. Bergman, 2023, Open forum infectious diseases.

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis

S. Cosgrove, P. Tamma, E. Avdic, 2018, Open forum infectious diseases.